gardisal sales disappoint, page-14

Interesting stock....no doubt about that.

$10m cap and $5m cash....and then you read the company presentation from the other day.

A couple of questions...given that Gribbles are now using their product.....what are the likely sales.

Does the Gribbles NPAAC validation allow other aussie companies to use the product........and if so why wouldSonic Healthcare in Australia not have the product in the market now.

I note in the US half the women population have an annual test (actualy seems a bit high, but thats what I have researched)....do we have any stats for Australia, or even further confirmation of that figure I quoted.

Thanks...in anticipation of a reply.